Friday, July 10, 2026

pharma · Not applicable, healthy volunteers · ulcerative pyoderma gangrenosum

InflaRx

InflaRx trial registry — 4 ClinicalTrials.gov studies with program phase, status, and indication context.

Jena, DE HQ
2007 Founded
52 Employees
EMA registrant Type
Company details
Status
Public
HQ
Jena, DE
Founded
2007
Employees
52
Programs
4
Drugs
20
Patents
0
Intelligence · Clinical Trials

InflaRx clinical trials

Registry index of 4 ClinicalTrials.gov studies linked to InflaRx programs — each row shows trial ID, program name, phase, status, and indication.

InflaRx trial registry — 4 ClinicalTrials.gov studies with program phase, status, and indication context.

Recent trial activity

4 updates

Latest clinical program signals indexed for InflaRx.

  1. IFX-1-P3.4 — Phase 3

    Clinical update
  2. INF904-P1.3 — Phase 1

    Clinical update
  3. INF904-P1.2 — Phase 1

    Clinical update
  4. INF904 — Phase 2

    Clinical update

Trial registry

4 studies
  1. 2024-515615-22-00

    INF904

    Phase 2 active small_molecule

    Moderate to Severe Chronic Spontaneous Urticaria (CSU) or Moderate to Severe Hidradenitis Suppurativa (HS)

    CTIS ↗